GlassScriptPhysician profile
Philip E Hill
NPI 1770583429
$20,629.96
in general payments reported to CMS, 2019-2025
36 companies · $2,213 in 2025
The $2,213 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,770 · 2020: $1,694 · 2021: $1,417 · 2022: $3,431 · 2023: $2,144 · 2024: $5,961 · 2025: $2,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,171 · Travel and Lodging: $2,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,171.08 |
| Travel and Lodging | $2,146.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,732.55 | 2019-2025 | Blueprint Patient Specific Instrumentation, Gamma, Axsos |
| Biotissue Holdings INC. | $3,199.44 | 2021-2025 | |
| Maxx Orthopedics, INC. | $2,000.00 | 2019 | |
| Polynovo North America LLC | $1,664.13 | 2023-2025 | Novosorb Btm |
| Advanced Orthopaedic Solutions, INC. | $1,528.11 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $931.56 | 2024-2025 | Iovera, Exparel, Zilretta |
| Corentec America INC | $833.93 | 2021-2022 | |
| Integra Lifesciences Corporation | $825.35 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Globus Medical, INC. | $548.82 | 2021-2023 | Xemplifi, Distal Femur Plate System, Evo Retrograde |
| Smith+Nephew, INC. | $407.61 | 2019-2025 | Pico 7, Pico 14, Renasys Go V2 Home |
| Organogenesis INC. | $391.08 | 2023-2025 | Puraply Wound Matrix, Puraply, Puraply Am |
| Aesculap Implant Systems, LLC | $318.69 | 2019-2020 | |
| In2bones USA, LLC | $268.13 | 2022 | |
| Kci USA, INC. | $241.46 | 2019-2023 | V.A.C. Veraflo |
| Linvatec Corporation | $187.71 | 2023-2024 | Biobrace 23mm, Linvatec Shoulder Arthroscopy, Allograft Tissue |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $167.79 | 2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $157.95 | 2019-2025 | Na, Monovisc |
| Amniox Medical, INC. | $144.34 | 2019 | |
| Zimmer Biomet Holdings, INC. | $135.96 | 2021 | |
| Biocomposites INC | $107.50 | 2019 | |
| Miach Orthopaedics, INC. | $102.32 | 2023 | |
| Carbofix Orthopedics INC | $97.84 | 2023 | |
| Paragon 28, INC. | $88.58 | 2023 | React |
| Maxx Health INC | $86.30 | 2025 | Summa Ortho Cannulated Screw, Summa Ortho Elbow |
| Bioventus LLC | $66.84 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $62.18 | 2024-2025 | |
| Saxum Surgical, INC. | $61.99 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $57.38 | 2023 | Seglentis |
| Encore Medical, LP | $46.76 | 2020 | |
| Dynasplint Systems INC. | $44.27 | 2025 | Dynasplint |
| Becton, Dickinson and Company | $32.86 | 2025 | Surgiphor |
| Biomarin Pharmaceutical INC. | $28.38 | 2019 | |
| Merck Sharp & Dohme LLC | $22.88 | 2022 | |
| Si-Bone, INC. | $15.75 | 2023 | |
| Guard Medical INC. | $15.00 | 2024 | Npseal Large |
| My01 INC. | $8.52 | 2023 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.